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ㅋ
Secondary achalasia due to submucosal invasion of esophageal squamous cell carcinoma (SCC) is a very rare condition. Here, 
we report a case of secondary achalasia diagnosed after distal esophagectomy, initially mistaken as primary achalasia. A 
51-year-old man presented with progressive dysphagia for 2 months and mild weight loss. A barium swallow study, endos-
copy, and manometry showed typical findings of primary achalasia. Pneumatic dilatation was performed, but esophageal per-
foration occurred as a complication. During surgical repair, no abnormalities around distal esophagus were found, and intra-
operative esophageal biopsy revealed only inflammatory cells. During the following 8 months, the patient suffered from dys-
phagia caused by recurrent esophageal obstruction several times although of repeated balloon dilatation and esophageal stent 
insertion. Finally, he received a distal esophagectomy. The postoperative pathology revealed SCC at the distal esophagus and 
esophagogastric junction. 
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Introduction
Achalasia is a rare swallowing disorder with an annual in-
cidence of 1 in every 100,000.
1 It is characterized by esophageal 
aperistalsis and abnormal lower esophageal sphincter relaxation 
in response to deglutition. The common form is primary or idio-
pathic achalasia, of which the cause remains unknown. Secondary 
forms of achalasia are less common, and various diseases includ-
ing esophageal cancer cause it.
Progressive dysphagia to solids followed by liquids is the 
most characteristic symptom of primary achalasia.
2 However, 
dysphagia in achalasia secondary to malignancy is relatively short 
in duration and usually develops when the malignant disease is far 
advanced. Therefore, a secondary form of achalasia caused by 
esophageal cancer can be easily diagnosed through upper gastro-
intestinal endoscopy. However, if esophageal cancer spreads into 
the submucosal layer, it is difficult to diagnose it until surgery.
Here, we report a case of secondary achalasia caused by sub-
mucosal invasion of esophageal cancer, initially mistaken as pri-Squamous Cell Carcinoma of the Lower Esophagus Mimicking Achalasia
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Figure 1. Barium esophagography and 
chest computed tomography (CT). (A) 
Barium esophagography demonstrates 
dilatation of distal esophagus and a bird’ 
beak appearance. (B) Chest CT shows 
no abnormality around distal esopha-
gus.
mary achalasia.
Case Report
A 51-year-old man presented with a 2-month history of pro-
gressive dysphagia for solids and liquids and a 2 kg body weight 
loss. There was no prior history of gastroesophageal (GE) reflux, 
odynophagia, or other gastrointestinal symptoms. Social history 
was negative for tobacco use and alcohol intake. Physical exami-
nation was unremarkable and routine, and laboratory tests were 
within normal limits. A barium swallow study revealed a mildly 
dilated esophagus and a smoothly narrowed esophagogastric 
junction (Fig. 1).
Esophageal manometry showed absence of peristalsis and ap-
parently incomplete relaxation of the lower esophageal sphincter, 
findings compatible with primary achalasia. A subsequent esoph-
agogastroduodenoscopy showed no evidence of gross mucosal le-
sions, although a mild resistance to the passage of the endoscope 
through the GE junction to the cardia was noted. On retroflexed 
view, the esophagogastric junction appeared normal. Blind biop-
sy at the GE junction was performed several times, but revealed 
no pathologic abnormality. 
A pneumatic dilation was performed using a 30 mm Rigiflex 
balloon dilator, which was inflated at 7 pound force per square 
inch for 1 minute (Fig. 2). After the procedure, the patient com-
plained of severe pain over the epigastrium, and a high fever 
(38.8
oC) developed. A computed tomography (CT) examination 
of the chest revealed pneumothorax and a small left pleural 
effusion. With the elevated white blood cell count and the con-
tinuous pain, the pleural effusion was interpreted as an infection, 
indicating that an operation was required. At left thoracotomy, 
about 150 mL of serosanguinous fluid and necrotic tissue debris 
was found in the pleural space. Intraoperative tissue biopsy re-
vealed only chronic active inflammation with abscess formation 
and fibrinoid necrosis. The esophagus was sutured primarily, and 
following copious irrigation, the pleural space was drained with 
tubes. The patient recovered well and was discharged without any 
symptoms of dysphagia. 
Four months later the patient’s dysphagia recurred. 
Endoscopy revealed food retention and complete obstruction of 
the GE junction. However, a thoraco-abdominal CT scan and 4 
biopsies from the mucosa of the GE junction did not reveal any 
abnormality. Because the patient refused surgical treatment, bal-
loon dilatation was performed several times, but dysphagia re-
curred soon after. And then, a 12-cm-long self-expandable metal 
stent (TaeWoong Medical CO. LTD., Goyang, Korea) was in-
serted into the distal esophagus. Dysphagia resolved, but a prox-
imal end of the stent was obstructed by ingrowing of normal 
esophageal mucosa. As a result of all these developments, the pa-
tient underwent surgical treatment. 
Sleeve gastrectomy and distal esophagectomy with esoph-
ago-gastrostomy was performed, and on pathologic examination, 
squamous cell carcinoma (SCC) was discovered at the distal 
esophagus (Fig. 3). For staging of esophageal cancer, a positron 
emission tomography-computed tomography (PET-CT) scan 
was taken after surgery, and showed a large and hypermetabolic 
mass in the remaining distal esophagus, compatible with esoph-
ageal cancer. In addition, metastatic lymphadenopathy in the per-
isplenic area and metastatic lesions in the right lung were shown 
(Fig. 4). Palliative chemotherapy, including 5-fluorouracil and 
cisplatin, was performed. And until now, he got fifth cycle of che-
motherapy and was well tolerated without complications related 
to the chemotherapy.J u n g  H o  P a r k,  e t  a l
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Figure 2. Esophageal rupture as a complication of pneumatic dilatation. (A) Chest X-ray and (B) chest computed tomography (CT) shows a left 
pleural effusion with the formation of a meniscus at the left costophrenic angle. (C) and (D) Chronic active inflammation with abscess formation and 
fibrinoid necrosis was noticed on the biopsy tissues (C: H&E, × 1.25, D: H&E, × 100).
Figure 3. Esophageal squamous cell carcinoma from surgical specimen of distal esophagectomy. (A) Nests of atypical squamous cell with a keratin 
pearl formation were seen (H&E, ×100). (B) Metastatic squamous cell carcinoma was seen in perigastric lymph node (×50).Squamous Cell Carcinoma of the Lower Esophagus Mimicking Achalasia
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Figure 4. (A) Chest computed tomo-
graphy (CT) revealed diffuse thicke-
ning of distal esophageal wall, which 
was mistaken as inflammatory reaction 
before distal esophagectomy, but was 
compatible with esophageal cancer 
(blue arrow: esophageal stent). (B) 
Markedly increased fluorodeoxyglu-
cose (FDG) uptake was noticed in the 
remaining distal esophagus and peris-
plenic area.
Discussion
Secondary achalasia caused by malignant disease is an in-
frequent disorder. It accounts for 2-4% of cases of achalasia
3,4 
and has been reported with various types of malignancies. Nearly 
75% of the patients with secondary achalasia are found to have 
underlying carcinoma of the cardia, but secondary achalasia may 
also be caused by SCC of the esophagus,
5 or by other malignant 
tumors that metastasize to the mediastinum or the GE junction, 
including carcinoma of the lung, breast, pancreas, uterus, and 
prostate gland.
6-8
Several mechanisms have been postulated to explain the 
pathogenesis of secondary achalasia. First, the tumor might di-
rectly infiltrate the nerves within the myenteric plexus of the 
esophagus, causing physical disruption of the myenteric plexus 
by the tumor and deposition of eosinophilic cationic protein.
9,10 
Second, a paraneoplastic syndrome might affect the function of 
the distal esophagus.
11 Third, esophageal obstruction might be 
caused by tumor infiltration or encasement of the GE junction. 
Secondary achalasia caused by gastric cardia cancer occurs after 
50% or more circumferential invasion of the GE junction,
12 and 
in the present case, histopathological study found a complete en-
casement of GE junction by SCC as well.
At first, after proper evaluation the patient’s dysphagia 
seemed to be caused by esophageal achalasia. However, when 
esophageal perforation occurred after pneumatic dilatation, 
lymph node enlargement or wall thickening of the esophagus was 
not noticed on Chest CT, and tissue biopsy revealed chronic in-
flammatory tissues only. Thus it was impossible to conclude that 
the patient’s symptoms were caused by malignancy. However, 
when obstruction of the GE junction recurred, esophageal cancer 
was seriously considered as a cause of secondary achalasia. The 
CT scan was rechecked and multiple biopsies were taken from 
the GE junction; however, there was no evidence of malignant in-
filtration at the GE junction. We then proposed performing 
PET-CT for verification of a hidden malignancy, but patient did 
not agree to receive PET-CT. Eight months later, we found a 
12-cm-long SCC arising around the GE junction. Considering 
there was no evidence of malignancy in earlier tissue biopsies or 
CT scan and the patient’s symptom of dysphagia in the begin-
ning, esophageal SCC might develop and progress submucosally, 
causing obstruction of GE junction. Even though such a case of 
SCC with submucosal progression is rare, there was a similar case 
report of a patient with SCC of the gastric cardia showing sub-
mucosal progression.
13 In the case we report, no abnormal lesions 
were detected by endoscopic biopsy and diagnosis was made only 
after surgery.
Secondary achalasia induced by malignant tumors has differ-
ent clinical features from primary achalasia. Secondary achalasia 
tends to occur at advanced age (more than 55 years), with short 
duration of symptoms (less than 6 months) and substantial 
weight loss at presentation [average weight loss 12 pounds (5.45 
kg)].
4 If these criteria are met, patients are recommended to un-
dergo additional imaging to rule out an occult malignancy. In our 
case, although the patient had short duration of symptoms (3 
months), he was only 51 years old and weight loss was only 2 kg 
during 3 months. This could be another reason why it was very 
difficult to make a correct diagnosis in the beginning.
In conclusion, secondary achalasia caused by malignancy is 
very rare; however, if a patient with dysphagia has clinical fea-
tures that suggest secondary achalasia or other unusual clinical 
outcomes such as restenosis, malignant diseases should be cau-
tiously considered before the diagnosis of primary achalasia. A 
CT scan, endoscopic ultrasonography, and PET scan will help in 
the diagnosis of achalasia.J u n g  H o  P a r k,  e t  a l
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